| |
 |
ARTICLES 
|
|
| The second chance for advanced Hodgkin's disease |
| GP Canellos |
|
JCO Feb 1 1992: 175–177.
[PDF]
|
 |
| Myeloma, melphalan, and meta-analysis |
| DE Bergsagel |
|
JCO Feb 1 1992: 178–179.
[PDF]
|
|
| Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer |
| SA Rosenberg |
|
JCO Feb 1 1992: 180–199.
[PDF]
|
|
|
The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse |
| |
CE Desch, MR Lasala, TJ Smith, and BE Hillner |
| |
JCO Feb 1 1992: 200–209.
[Abstract]
[PDF]
|
|
|
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure |
| |
DL Longo, PL Duffey, RC Young, SM Hubbard, DC Ihde, E Glatstein, JC Phares, ES Jaffe, WJ Urba, and VT DeVita, Jr |
| |
JCO Feb 1 1992: 210–218.
[Abstract]
[PDF]
|
|
|
MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study |
| |
U Vitolo, M Bertini, E Brusamolino, GB Cavallero, B Comotti, E Gallo, R Ghio, A Levis, G Luxi, and V Meneghini |
| |
JCO Feb 1 1992: 219–227.
[Abstract]
[PDF]
|
|
|
A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma |
| |
U Tirelli, V Zagonel, D Errante, D Serraino, R Talamini, M De Cicco, A Carbone, and S Monfardini |
| |
JCO Feb 1 1992: 228–236.
[Abstract]
[PDF]
|
|
|
Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia |
| |
EA Copelan, JC Biggs, BR Avalos, J Szer, I Cunningham, JP Klein, K Atkinson, N Kapoor, JL Klein, and K Downs |
| |
JCO Feb 1 1992: 237–242.
[Abstract]
[PDF]
|
|
|
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease |
| |
M Markman, T Hakes, B Reichman, JL Lewis, Jr, S Rubin, W Jones, L Almadrones, F Pizzuto, and W Hoskins |
| |
JCO Feb 1 1992: 243–248.
[Abstract]
[PDF]
|
|
|
Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study |
| |
HS Friedman, JP Krischer, P Burger, WJ Oakes, B Hockenberger, MD Weiner, JM Falletta, D Norris, AH Ragab, and DH Mahoney, Jr |
| |
JCO Feb 1 1992: 249–256.
[Abstract]
[PDF]
|
|
|
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck |
| |
C Jacobs, G Lyman, E Velez-Garcia, KS Sridhar, W Knight, H Hochster, LT Goodnough, JE Mortimer, LH Einhorn, and L Schacter |
| |
JCO Feb 1 1992: 257–263.
[Abstract]
[PDF]
|
|
|
Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation |
| |
TE Goffman, LJ Dachowski, H Bobo, EH Oldfield, SM Steinberg, J Cook, JB Mitchell, D Katz, R Smith, and E Glatstein |
| |
JCO Feb 1 1992: 264–268.
[Abstract]
[PDF]
|
|
|
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer |
| |
D Kelsen, D Lovett, J Wong, L Saltz, M Buckley, P Murray, R Heelan, and C Lightdale |
| |
JCO Feb 1 1992: 269–274.
[Abstract]
[PDF]
|
|
|
A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma |
| |
GR Weiss, KA Margolin, FR Aronson, M Sznol, MB Atkins, JP Dutcher, ER Gaynor, DH Boldt, JH Doroshow, and MH Bar |
| |
JCO Feb 1 1992: 275–281.
[Abstract]
[PDF]
|
|
|
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group |
| |
BJ Roth, DH Johnson, LH Einhorn, LP Schacter, NC Cherng, HJ Cohen, J Crawford, JA Randolph, JL Goodlow, and GO Broun |
| |
JCO Feb 1 1992: 282–291.
[Abstract]
[PDF]
|
|
|
Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial |
| |
TM Waits, DH Johnson, JD Hainsworth, KR Hande, M Thomas, and FA Greco |
| |
JCO Feb 1 1992: 292–296.
[Abstract]
[PDF]
|
|
|
Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer |
| |
R Feld, R Wierzbicki, PL Walde, FA Shepherd, WK Evans, S Gupta, P Shannon, and M Lassus |
| |
JCO Feb 1 1992: 297–303.
[Abstract]
[PDF]
|
|
|
Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients |
| |
CK Osborne, VJ Wiebe, WL McGuire, DR Ciocca, and MW DeGregorio |
| |
JCO Feb 1 1992: 304–310.
[Abstract]
[PDF]
|
|
|
Increased teniposide clearance with concomitant anticonvulsant therapy |
| |
DK Baker, MV Relling, CH Pui, ML Christensen, WE Evans, and JH Rodman |
| |
JCO Feb 1 1992: 311–315.
[Abstract]
[PDF]
|
|
|
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule |
| |
JA Talcott, RD Siegel, R Finberg, and L Goldman |
| |
JCO Feb 1 1992: 316–322.
[Abstract]
[PDF]
|
|
|
A population-based study of neuroblastoma incidence, survival, and mortality in North America [published erratum appears in J Clin Oncol 1992 Jul;10(7):1202] |
| |
ML Bernstein, JM Leclerc, G Bunin, L Brisson, L Robison, J Shuster, T Byrne, D Gregory, G Hill, and G Dougherty |
| |
JCO Feb 1 1992: 323–329.
[Abstract]
[PDF]
|
|
|
Telephone counseling improves adherence to colposcopy among lower- income minority women |
| |
C Lerman, P Hanjani, C Caputo, S Miller, E Delmoor, S Nolte, and P Engstrom |
| |
JCO Feb 1 1992: 330–333.
[Abstract]
[PDF]
|
|
|
Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials |
| |
WM Gregory, MA Richards, and JS Malpas |
| |
JCO Feb 1 1992: 334–342.
[Abstract]
[PDF]
|
|
| Neoadjuvant chemotherapy in head and neck cancer: no way to preserve a larynx |
| IF Tannock and BJ Cummings |
|
JCO Feb 1 1992: 343–345.
[PDF]
|
|
| American Joint Committee on Cancer Classification for Melanoma |
| GJ Hill |
|
JCO Feb 1 1992: 345–346.
[PDF]
|
|
| Burnout syndrome among oncologists |
| JA Axelson and RH Clark |
|
JCO Feb 1 1992: 346.
[PDF]
|
|
